Agile Therapeutics, Inc. (AGRX Quick QuoteAGRX - Free Report) was a big mover last session, as its shares rose almost 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.04 to $2.48 in the past one-month time frame.

The company has seen three positive and one negative estimate revisions in the past 30 days. The Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.

Agile Therapeutics currently carries a Zacks Rank #3 (Hold).

Agile Therapeutics, Inc. Price

 

Agile Therapeutics, Inc. Price | Agile Therapeutics, Inc. Quote

A better-ranked stock in the Medical - Generic Drugs space is Zynerba Pharmaceuticals, Inc. , carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is AGRX going up? Or down? Predict to see what others think: Up or Down

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>